BioMarin Pharmaceutical, Inc. (BMRN)
57.90
+1.35
(+2.39%)
USD |
NASDAQ |
Jun 09, 16:00
57.50
-0.40
(-0.69%)
After-Hours: 18:18
BioMarin Pharmaceutical SG&A Expense (Quarterly) : 258.30M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 150.36M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Incyte Corp. | 328.09M |
| Mirum Pharmaceuticals, Inc. | 96.33M |
| Cytokinetics, Inc. | 104.90M |